Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris

European Journal of Preventive Cardiology

Volumn 22, Issue 5, 2015, Pages 606-614

  Schartum Hansen, Hall ^a,b   Pedersen, Eva R ^a   Svingen, Gard F T ^a   Ueland, Per M ^a,b   Seifert, Reinhard ^b   Ebbing, Marta ^b   Strand, Elin ^a   Bleie, Øyvind ^b   Nygård, Ottar ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Betaine; biomarker; choline; long term prognosis; smoking; stable angina pectoris

Indexed keywords

BETAINE; C REACTIVE PROTEIN; CHOLINE; TROPONIN T; BIOLOGICAL MARKER; VITAMIN; VITAMIN B COMPLEX;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; STABLE ANGINA PECTORIS; BLOOD; CORONARY ANGIOGRAPHY; CORONARY BLOOD VESSEL; HEART INFARCTION; METABOLISM; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL;

AGED; ANGINA, STABLE; BETAINE; BIOMARKERS; C-REACTIVE PROTEIN; CHOLINE; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROSPECTIVE STUDIES; SMOKING; TROPONIN T; VITAMIN B COMPLEX; VITAMINS;

EID: 84927614050     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487314524867     Document Type: Article

References (39)

1. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008 ; 49: 1187-1194
2. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev. 2009 ; 67: 615-623
3. Lin CS, Wu RD. Choline oxidation and choline dehydrogenase. J Protein Chem. 1986 ; 5: 193-200
4. Holm PI, Ueland PM, Vollset SE, et al. Betaine and folate status as cooperative determinants of plasma homocysteine in humans. Arterioscler Thromb Vasc Biol. 2005 ; 25: 379-385
5. Konstantinova SV, Tell GS, Vollset SE, et al. Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J Nutr. 2008 ; 138: 914-920
6. Wang Z, Klipfell E, Bennett BJ, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011 ; 472: 57-63
7. Tang WH, Wang Z, Levison BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013 ; 368: 1575-1584
8. Morrow DA, Cannon CP, Jesse RL, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation. 2007 ; 115: e356-e375
9. Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta. 2006 ; 369: 179-187
10. Muller O, Barbato E, De Bruyne B, et al. Biomarkers of vulnerable plaque: the missing link with ischemia. Biomark Med. 2010 ; 4: 375-383
11. Danne O, Mockel M. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev Mol Diagn. 2010 ; 10: 159-171
12. Bruhl A, Hafner G, Loffelholz K. Release of choline in the isolated heart, an indicator of ischemic phospholipid degradation and its protection by ischemic preconditioning: no evidence for a role of phospholipase D. Life Sci. 2004 ; 75: 1609-1620
13. Imajo K, Fujita K, Yoneda M, et al. Plasma free choline is a novel non-invasive biomarker for early-stage non-alcoholic steatohepatitis: a multi-center validation study. Hepatol Res. 2012 ; 42: 757-766
14. Bhatia LS, Curzen NP, Calder PC, et al. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J. 2012 ; 33: 1190-1200
15. Svingen GF, Ueland PM, Pedersen EK, et al. Plasma dimethylglycine and risk of incident acute myocardial infarction in patients with stable angina pectoris. Arterioscler Thromb Vasc Biol. 2013 ; 33: 2041-2048
16. Ying J, Rahbar MH, Hallman DM, et al. Associations between dietary intake of choline and betaine and lung cancer risk. PLoS One. 2013 ; 8: e54561-e54561
17. Frey B, Haupt R, Alms S, et al. Increase in fragmented phosphatidylcholine in blood plasma by oxidative stress. Journal of Lipid Research. 2000 ; 41: 1145-1153
18. Padmavathi P, Reddy VD, Maturu P, et al. Smoking-induced alterations in platelet membrane fluidity and Na(+)/K(+)-ATPase activity in chronic cigarette smokers. J Atheroscler Thromb. 2010 ; 17: 619-627
19. Rival J, Riddle JM, Stein PD. Effects of chronic smoking on platelet function. Thromb Res. 1987 ; 45: 75-85
20. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012; 19: 585-667.
21. Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA. 2008 ; 300: 795-804
22. Holm PI, Ueland PM, Kvalheim G, et al. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem. 2003 ; 49: 286-294
23. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009 ; 302: 2119-2126
24. Koenker R Quantile regression. New York: Cambridge University Press ; 2005 :
25. Body R, Griffith CA, Keevil B, et al. Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. Clin Chim Acta. 2009 ; 404: 89-94
26. Danne O, Mockel M, Lueders C, et al. Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am J Cardiol. 2003 ; 91: 1060-1067
27. LeLeiko RM, Vaccari CS, Sola S, et al. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am J Cardiol. 2009 ; 104: 638-643
28. Mockel M, Danne O, Muller R, et al. Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes. Clin Chim Acta. 2008 ; 393: 103-109
29. Cavusoglu E, Chhabra S, Jiang XC, et al. Relation of baseline plasma phospholipid levels to cardiovascular outcomes at two years in men with acute coronary syndrome referred for coronary angiography. Am J Cardiol. 2007 ; 100: 1739-1743
30. Lever M, George PM, Elmslie JL, et al. Betaine and secondary events in an acute coronary syndrome cohort. PLoS One. 2012 ; 7: e37883-e37883
31. Bidulescu A, Chambless LE, Siega-Riz AM, et al. Usual choline and betaine dietary intake and incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc Disord. 2007 ; 7: 20-20
32. Dalmeijer GW, Olthof MR, Verhoef P, et al. Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur J Clin Nutr. 2008 ; 62: 386-394
33. Danne O, Mockel M. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev Mol Diagn. 2010 ; 10: 159-171
34. Ketelhuth DF, Back M. The role of matrix metalloproteinases in atherothrombosis. Curr Atheroscler Rep. 2011 ; 13: 162-169
35. Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program. 2011 ; 2011: 51-61
36. Tsuda T, Yoshimura H, Hamasaki N. Effect of phosphatidylcholine, phosphatidylethanolamine and lysophosphatidylcholine on the activated factor X-prothrombin system. Blood Coagul Fibrinolysis. 2006 ; 17: 465-469
37. Burke A, Fitzgerald GA. Oxidative stress and smoking-induced vascular injury. Prog Cardiovasc Dis. 2003 ; 46: 79-90
38. Watson AD, Leitinger N, Navab M, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997 ; 272: 13597-13607
39. Volzke H, Schmidt CO, Baumeister SE, et al. Personalized cardiovascular medicine: concepts and methodological considerations. Nat Rev Cardiol. 2013 ; 10: 308-316